ENTA: AbbVie Gets EU Approval
Enanta Pharmaceuticals' partner AbbVie receives European Commission approval of MAVIRET for people with acute Hepatitis C Virus
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Abbvie Gets EU Approval
Abbvie receives EU approval for Maviret, a Hepatitis C treatment